Torp-Pedersen C - Search Results

1

Analysis of stroke in ATHENA: a placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutter.

Connolly SJ, Crijns HJ, Torp-Pedersen C, van Eickels M, Gaudin C, Page RL, Hohnloser SH; ATHENA Investigators. Connolly SJ, et al. Circulation. 2009 Sep 29;120(13):1174-80. doi: 10.1161/CIRCULATIONAHA.109.875252. Epub 2009 Sep 14. Circulation. 2009. PMID: 19752319

2

Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction.

Pedersen OD, Bagger H, Kober L, Torp-Pedersen C. Pedersen OD, et al. Circulation. 1999 Jul 27;100(4):376-80. doi: 10.1161/01.cir.100.4.376. Circulation. 1999. PMID: 10421597 Clinical Trial.

3

Qtc interval as a guide to select those patients with congestive heart failure and reduced left ventricular systolic function who will benefit from antiarrhythmic treatment with dofetilide.

Brendorp B, Elming H, Jun L, Køber L, Malik M, Jensen GB, Torp-Pedersen C; DIAMOND Study Group. Brendorp B, et al. Circulation. 2001 Mar 13;103(10):1422-7. doi: 10.1161/01.cir.103.10.1422. Circulation. 2001. PMID: 11245647 Clinical Trial.

4

Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish investigations of arrhythmia and mortality on dofetilide (diamond) substudy.

Pedersen OD, Bagger H, Keller N, Marchant B, Køber L, Torp-Pedersen C. Pedersen OD, et al. Circulation. 2001 Jul 17;104(3):292-6. doi: 10.1161/01.cir.104.3.292. Circulation. 2001. PMID: 11457747 Clinical Trial.

5

Temporal trends on the risk of arrhythmic vs. non-arrhythmic deaths in high-risk patients after myocardial infarction: a combined analysis from multicentre trials.

Yap YG, Duong T, Bland M, Malik M, Torp-Pedersen C, Køber L, Connolly SJ, Marchant B, Camm J. Yap YG, et al. Eur Heart J. 2005 Jul;26(14):1385-93. doi: 10.1093/eurheartj/ehi268. Epub 2005 May 24. Eur Heart J. 2005. PMID: 15914501

6

New antiarrhythmic agents for atrial fibrillation and atrial flutter.

Pecini R, Elming H, Pedersen OD, Torp-Pedersen C. Pecini R, et al. Expert Opin Emerg Drugs. 2005 May;10(2):311-22. doi: 10.1517/14728214.10.2.311. Expert Opin Emerg Drugs. 2005. PMID: 15934869 Review.

7

Prognostic impact of demographic factors and clinical features on the mode of death in high-risk patients after myocardial infarction--a combined analysis from multicenter trials.

Yap YG, Duong T, Bland JM, Malik M, Torp-Pedersen C, Køber L, Connolly SJ, Marchant B, Camm AJ. Yap YG, et al. Clin Cardiol. 2005 Oct;28(10):471-8. doi: 10.1002/clc.4960281006. Clin Cardiol. 2005. PMID: 16274095 Free PMC article.

8

Potential demographic and baselines variables for risk stratification of high-risk post-myocardial infarction patients in the era of implantable cardioverter-defibrillator--a prognostic indicator.

Yap YG, Duong T, Bland M, Malik M, Torp-Pedersen C, Køber L, Connolly SJ, Gallagher MM, Camm AJ. Yap YG, et al. Int J Cardiol. 2008 May 7;126(1):101-7. doi: 10.1016/j.ijcard.2007.03.122. Epub 2007 May 17. Int J Cardiol. 2008. PMID: 17499864

9

Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non-inferiority trial.

Amadeus Investigators; Bousser MG, Bouthier J, Büller HR, Cohen AT, Crijns H, Davidson BL, Halperin J, Hankey G, Levy S, Pengo V, Prandoni P, Prins MH, Tomkowski W, Torp-Pedersen C, Wyse DG. Amadeus Investigators, et al. Lancet. 2008 Jan 26;371(9609):315-21. doi: 10.1016/S0140-6736(08)60168-3. Lancet. 2008. PMID: 18294998 Clinical Trial.

10

Vernakalant hydrochloride for rapid conversion of atrial fibrillation: a phase 3, randomized, placebo-controlled trial.

Roy D, Pratt CM, Torp-Pedersen C, Wyse DG, Toft E, Juul-Moller S, Nielsen T, Rasmussen SL, Stiell IG, Coutu B, Ip JH, Pritchett EL, Camm AJ; Atrial Arrhythmia Conversion Trial Investigators. Roy D, et al. Circulation. 2008 Mar 25;117(12):1518-25. doi: 10.1161/CIRCULATIONAHA.107.723866. Epub 2008 Mar 10. Circulation. 2008. PMID: 18332267 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,461 results

Search Page

Filters